NeurologyOphthalmology
Idiopathic Intracranial Hypertension
Modified Dandy criteria, MRI/MRV, LP for opening pressure, weight loss, acetazolamide, surgical options for refractory vision loss.
Source: ABN; consensus 2018
Step 1 of ~3
info
Recognise + Workup
Modified Dandy criteria: signs/symptoms of raised ICP (headache worse on Valsalva / lying flat / morning, transient visual obscurations, pulsatile tinnitus, papilloedema, diplopia from VI palsy); normal neurological exam except papilloedema ± VI palsy; no other cause of raised ICP; opening pressure >25 cm H₂O at LP (in correctly positioned adult). Risk: female, obese (BMI >30), reproductive age. Drugs: tetracyclines, retinoids, lithium, growth hormone, OCP (controversial).
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Tranexamic Acid (ICU/Trauma/Surgical) · Antifibrinolytic
- Ranolazine · Refractory Stable Angina
- Selexipag · Pulmonary Arterial Hypertension
- Macitentan · Pulmonary Arterial Hypertension
- Hydrocortisone (Oral Replacement) · Glucocorticoid Replacement
- Prednisolone (Sudden Sensorineural Hearing Loss) · Corticosteroid (systemic — SSNHL treatment)
Pathways
- Acute Stroke / TIA Assessment · NICE NG128; RCP Stroke Guidelines 2023
- Status Epilepticus (Adults) · NICE CG137; ESEM guidelines; RCP Neurology Guidelines
- Suspected Subarachnoid Haemorrhage · NICE NG228; RCEM 2023; AHA/ASA 2023
- Adult Head Injury · NICE NG232 (2023)
- Bell's Palsy / Facial Nerve Palsy · ENT UK 2017; AAN
- Vertigo Workup · ENT UK; NICE CKS
Featured in these MRCEM clinical pathways
A deeper exam-focused version of this pathway is available on our sister siteReviseMRCEM.
MRCEM Primary / Intermediate / OSCE candidates: each pathway includes exam-style questions, RCEM/NICE citations, and FAQ summaries.
Decision support only. Always apply local guidelines and clinical judgement.